Beliefs, knowledge and the impact of COVID19 on menopause therapies in Spanish women: COMEM‑treatment study Baquedano, Laura Mendoza Ladrón De Guevara, Nicolás COMEM Study Spanish investigators Menopause hormone therapy Knowledge Menopause COVID-19 Confinement Spanish investigators involved in the COMEM Study: Laura Baquedano, Andrea Espiau, Silvia Ortega, Leyre Ruiz, Marta Lamarca, Yasmina José, Patricia Rubio, Francisco Villalobos, Amparo Borque, Peña Dieste, Lourdes Gabasa, Virginia Roy, María J Puente, Marta Chóliz, Laura Cotaina, Isabel Negredo, Pilar del Tiempo, Hortensia Yagüe, Mónica Hernnández (Hospital Universitario Miguel Servet of Zaragoza), Pilar D Tajada (Hospital San Jorge of Huesca), María Fasero (Hospital Universitario La Zarzuela of Madrid), I Ramirez (Hospital San Carlos of San Fernando), Luisa Gutiérrez (Hospital Insular-Materno Infantil of Las Palmas), Fernando Colmenarejo (Hospital Quirón Salud of Zaragoza), Pluvio J Coronado (Hospital Clínico San Carlos of Madrid), Teresa Aznar (Hospital Universitario of Castellón), Jesús Presa (Complejo Hospitalario of Jaén), Placido Llaneza (Hospital Universitario Central of Asturias), Rafael Sánchez-Borrego (Clínica Diatros of Barcelona), Santiago Palacios (Instituto Palacios of Madrid) and Ana R Jurado (European Institute of Sexology, Marbella). The team of seven menopause experts who conducted the survey was composed of: L Baquedano, P Coronado, N Mendoza, I Ramirez, E de la Viuda, B Otero and S Sánchez. This article has been translated and edited by Your English Lab. Objective To study what women think about menopause treatments and assess their knowledge about them. To analyze adherence to treatment during COVID-19 confinement as a secondary objective. Methods A multi-center cross-sectional observational study was conducted using a survey of 2500 women between January and June 2019. This was administered following a non-probability sampling procedure including women between 35 and 75 years. An extension study was conducted during the coronavirus pandemic, between March and June 2020. Results The responses of 2355 surveyed women were analyzed. Of this sample, 42% knew about menopause hormone therapy (MHT). The most frequently identified indication was the treatment of hot flashes (65.6%). The MHT risks most frequently perceived were weight gain (24.2%) and breast cancer (21.7%); the main reason for rejecting MHT was a lack of information (96.1%). Comparative analyses were conducted according to age, menopausal status, type of menopause, place of residence, type of health care and level of education. During the coronavirus confinement period, 85 women using MHT were located, of which 84.7% continued it. Conclusions Women hold certain false beliefs about menopause, and their knowledge of the available treatments is somewhat limited. Adherence to MHT during the COVID-19 confinement in Spain has been high. 2021-01-26T13:27:25Z 2021-01-26T13:27:25Z 2020-12-28 info:eu-repo/semantics/article Baquedano, L., Espiau, A., Fasero, M. et al. Beliefs, knowledge and the impact of COVID19 on menopause therapies in Spanish women: COMEM-treatment study. BMC Women's Health 20, 277 (2020). [https://doi.org/10.1186/s12905-020-01151-x] http://hdl.handle.net/10481/66036 10.1186/s12905-020-01151-x eng http://creativecommons.org/licenses/by/3.0/es/ info:eu-repo/semantics/openAccess Atribución 3.0 España Springer Nature